Version française

Stago at the Heart of Haemostasis

People dedicated to Health

From ideas...to medical applications

Complications of heparin treatment

In the absence of any straightforward laboratory tests, the most severe complication, known as type II heparin-induced thrombocytopenia (HIT) has...

From ideas...to medical applications

STA-Procoag-PPL or making microparticles talk

Midway between plasma haemostasis and cellular haemostasis are microparticles, rich in procoagulant phospholipids. An increase in this procoagulant...

From ideas...to medical applications

Remaining abreast of changes in biomedical science

Listening to and exchanging ideas with members of the biomedical science community has enabled Stago to develop its expertise in the search for...

From ideas...to medical applications

Complete industrial autonomy

Achieving a balanced policy with regard to investment in research & development (R&D), technological monitoring and rational acquisitions is a key...

Events

All news

Tablets App

android appiPad App

This free educational application in English is the first of its kind and has been developed by an expert in Haemostasis… Stago.

Products & Services

New range of STA®-Routine QC quality control plasmas: The best range for routine laboratory tests

To fulfil regulatory requirements, laboratories must perform regular internal quality control (IQC) on at least two concentration levels (normal and abnormal) to check and confirm the performance of their testing systems.

Stago Catalogue

Did you know?

Heparin was discovered independently in 1911 by Doyon and in 1916 by McLean, for different reasons. The effect of heparin on blood clotting, however, had been observed one-third of a century earlier.

RSS feed | Contact us | Credits and copyrights | Disclaimer | Site map | Cookies